This six-part fact sheet series examines the contributions of US government agencies to advancing global health R&D. The series includes the US Agency for International Development, National Institutes of Health, Centers for Disease Control and Prevention, Biomedical Advanced Research and Development Authority, Department of Defense, and Food and Drug Administration.
Ahead of the 2023 reauthorization of the Biomedical Advanced Research and Development Authority (BARDA), the Pandemic and All Hazards Preparedness Act (PAHPA) 2023 policy memo outlines GHTC’s priorities for the reauthorization of BARDA.
Video introducing Pretomanid as GHTC’s 2022 Innovating for Impact Partnership Award honoree.
Outlines a policy proposal for a Supporting Innovative Global Health Technologies (SIGHT) Fund to create a new and additive source of flexible, catalytic funding at the US Agency for International Development (USAID) to conduct research, development, and deployment of global health products through a new appropriation to the USAID Global Health Bureau.
Find out about GHTC’s membership options and the benefits of becoming a member.
Learn MoreWe bring together nonprofits, academic institutions, and aligned businesses that are committed to advancing health equity through innovation.
